These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

748 related articles for article (PubMed ID: 17128270)

  • 1. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation.
    Lee SH; Rho J; Jeong D; Sul JY; Kim T; Kim N; Kang JS; Miyamoto T; Suda T; Lee SK; Pignolo RJ; Koczon-Jaremko B; Lorenzo J; Choi Y
    Nat Med; 2006 Dec; 12(12):1403-9. PubMed ID: 17128270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell fusion in osteoclasts plays a critical role in controlling bone mass and osteoblastic activity.
    Iwasaki R; Ninomiya K; Miyamoto K; Suzuki T; Sato Y; Kawana H; Nakagawa T; Suda T; Miyamoto T
    Biochem Biophys Res Commun; 2008 Dec; 377(3):899-904. PubMed ID: 18952053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CSF-1 in bone and bone marrow development.
    Cecchini MG; Hofstetter W; Halasy J; Wetterwald A; Felix R
    Mol Reprod Dev; 1997 Jan; 46(1):75-83; discussion 83-4. PubMed ID: 8981367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vacuolar-type H+-ATPase-mediated acidosis promotes in vitro osteoclastogenesis via modulation of cell migration.
    Kim JM; Min SK; Kim H; Kang HK; Jung SY; Lee SH; Choi Y; Roh S; Jeong D; Min BM
    Int J Mol Med; 2007 Mar; 19(3):393-400. PubMed ID: 17273786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells.
    Yagi M; Miyamoto T; Sawatani Y; Iwamoto K; Hosogane N; Fujita N; Morita K; Ninomiya K; Suzuki T; Miyamoto K; Oike Y; Takeya M; Toyama Y; Suda T
    J Exp Med; 2005 Aug; 202(3):345-51. PubMed ID: 16061724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luteolin inhibition of V-ATPase a3-d2 interaction decreases osteoclast resorptive activity.
    Crasto GJ; Kartner N; Yao Y; Li K; Bullock L; Datti A; Manolson MF
    J Cell Biochem; 2013 Apr; 114(4):929-41. PubMed ID: 23129004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific inhibitors of vacuolar H(+)-ATPase trigger apoptotic cell death of osteoclasts.
    Okahashi N; Nakamura I; Jimi E; Koide M; Suda T; Nishihara T
    J Bone Miner Res; 1997 Jul; 12(7):1116-23. PubMed ID: 9200012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vacuolar H+-ATPase d2 subunit: molecular characterization, developmental regulation, and localization to specialized proton pumps in kidney and bone.
    Smith AN; Jouret F; Bord S; Borthwick KJ; Al-Lamki RS; Wagner CA; Ireland DC; Cormier-Daire V; Frattini A; Villa A; Kornak U; Devuyst O; Karet FE
    J Am Soc Nephrol; 2005 May; 16(5):1245-56. PubMed ID: 15800125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrm1 interacts with Atp6v0d2 and regulates osteoclast differentiation.
    Kim T; Ha HI; Kim N; Yi O; Lee SH; Choi Y
    Biochem Biophys Res Commun; 2009 Dec; 390(3):585-90. PubMed ID: 19818731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic identification of the TRAF6 regulation of vacuolar ATPase for osteoclast function.
    Ryu J; Kim H; Lee SK; Chang EJ; Kim HJ; Kim HH
    Proteomics; 2005 Nov; 5(16):4152-60. PubMed ID: 16196101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered hematopoiesis in glypican-3-deficient mice results in decreased osteoclast differentiation and a delay in endochondral ossification.
    Viviano BL; Silverstein L; Pflederer C; Paine-Saunders S; Mills K; Saunders S
    Dev Biol; 2005 Jun; 282(1):152-62. PubMed ID: 15936336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP).
    Kim K; Lee SH; Ha Kim J; Choi Y; Kim N
    Mol Endocrinol; 2008 Jan; 22(1):176-85. PubMed ID: 17885208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid blasts are the mouse bone marrow cells prone to differentiate into osteoclasts.
    de Vries TJ; Schoenmaker T; Hooibrink B; Leenen PJ; Everts V
    J Leukoc Biol; 2009 Jun; 85(6):919-27. PubMed ID: 19304896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disordered osteoclast formation and function in a CD38 (ADP-ribosyl cyclase)-deficient mouse establishes an essential role for CD38 in bone resorption.
    Sun L; Iqbal J; Dolgilevich S; Yuen T; Wu XB; Moonga BS; Adebanjo OA; Bevis PJ; Lund F; Huang CL; Blair HC; Abe E; Zaidi M
    FASEB J; 2003 Mar; 17(3):369-75. PubMed ID: 12631576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Regulatory mechanisms of osteoclast differentiation and function].
    Takahashi N
    Clin Calcium; 2006 Jun; 16(6):940-47. PubMed ID: 16751689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoclast culture and resorption assays.
    Bradley EW; Oursler MJ
    Methods Mol Biol; 2008; 455():19-35. PubMed ID: 18463808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treg cells suppress osteoclast formation: a new link between the immune system and bone.
    Zaiss MM; Axmann R; Zwerina J; Polzer K; Gückel E; Skapenko A; Schulze-Koops H; Horwood N; Cope A; Schett G
    Arthritis Rheum; 2007 Dec; 56(12):4104-12. PubMed ID: 18050211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification.
    Li YP; Chen W; Liang Y; Li E; Stashenko P
    Nat Genet; 1999 Dec; 23(4):447-51. PubMed ID: 10581033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of morphological effects of PGE2 and TGFbeta on osteoclastogenesis induced by RANKL in mouse bone marrow cell cultures.
    Gardner CR
    Cell Tissue Res; 2007 Oct; 330(1):111-21. PubMed ID: 17694327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor activator of nuclear factor-kappaB ligand-induced mouse osteoclast differentiation is associated with switching between NADPH oxidase homologues.
    Sasaki H; Yamamoto H; Tominaga K; Masuda K; Kawai T; Teshima-Kondo S; Matsuno K; Yabe-Nishimura C; Rokutan K
    Free Radic Biol Med; 2009 Jul; 47(2):189-99. PubMed ID: 19409483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.